KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Debt to Equity (2016 - 2025)

Thermo Fisher Scientific's Debt to Equity history spans 17 years, with the latest figure at $0.74 for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 16.82% year-over-year to $0.74, compared with a TTM value of $0.74 through Dec 2025, up 16.82%, and an annual FY2025 reading of $0.74, up 16.82% over the prior year.
  • Debt to Equity for Q4 2025 was $0.74 at Thermo Fisher Scientific, up from $0.7 in the prior quarter.
  • The five-year high for Debt to Equity was $0.85 in Q4 2021, with the low at $0.51 in Q3 2021.
  • Average Debt to Equity over 5 years is $0.71, with a median of $0.73 recorded in 2024.
  • Year-over-year, Debt to Equity decreased 28.67% in 2021 and then skyrocketed 52.49% in 2022.
  • Tracing TMO's Debt to Equity over 5 years: stood at $0.85 in 2021, then fell by 8.23% to $0.78 in 2022, then dropped by 4.59% to $0.75 in 2023, then dropped by 15.54% to $0.63 in 2024, then increased by 16.82% to $0.74 in 2025.
  • Per Business Quant, the three most recent readings for TMO's Debt to Equity are $0.74 (Q4 2025), $0.7 (Q3 2025), and $0.7 (Q2 2025).